Opioid agonist treatment. Guiding principles for legislation and regulations
Por su acción farmacológica, los medicamentos agonistas opioides recetados para el tratamiento del síndrome de dependencia de opioides tienen efectos muy diferentes de los opioides utilizados con fines hedónicos en un entorno no médico. Implementados de acuerdo con los arreglos apropiados, estos med...
I tiakina i:
| Kaituhi matua: | |
|---|---|
| Ētahi atu kaituhi: | |
| Hōputu: | Monograph |
| Reo: | Ingarihi |
| I whakaputaina: |
Estrasburgo
Council of Europe
2017
|
| Ngā marau: | |
| Urunga tuihono: | Enlace web Servidor |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Ngā tūemi rite: Opioid agonist treatment. Guiding principles for legislation and regulations
- How to regulate stimulants. A practical guide
- Balancing access to opioid substitution treatment with preventing the diversion of opioid substitution medications in Europe: challenges and implications
- Community led monitoring of opioid agonist treatment including WHO quality of life indicators
- Législations nationales et politiques de réduction des dommages liés à l'alcool au sein de l'Union Européenne
- Roadmaps to regulation: MDMA
- The spectre of article 14: the INCB report for 2021, regulated cannabis markets and the board’s potential enforcement measures